Characterization of antigen-expressing Plasmodium falciparum cDNA clones that are reactive with parasite inhibitory antibodies

https://doi.org/10.1016/0166-6851(88)90127-2Get rights and content

Abstract

A Plasmodium falciparum (FCR3 strain) λgt11 cDNA expression library was constructed from trophozoite and schizont poly(A) RNA and was screened immunologically with a pooled human immune serum from Nigeria to form a gene bank of 288 positive clones. The gene bank was subsequently screened with parasite inhibitory mouse monoclonal antibodies (mMAb) and with individual human Liberian sera. Two mMAb, 43E5 and 5H10, strongly reacted with 8 and 3 cDNA clones, respectively. Several of those clones also weakly cross-reacted with the other mMAb. Two of those weakly cross-reactive clones, cDNA#366 and cDNA#22, were shown to be located in different chromosomal regions of the parasite by Southern hybridization and so appeared to represent two different parasite genes. The genomic organization of both cDNA#366 and cDNA#22 sequences were identical in the FCR3 and the Honduras-1 strains. The nucleotide sequence of cDNA#366 and the amino acid sequence it coded for were homologous to a partial DNA and amino acid sequence previously reported for a P. falciparum (Camp strain) exoantigen designated p126 [1]. The mRNA for cDNA#366 appeared to represent an abundant message in blood stage trophozoites and schizonts.

References (29)

  • D.J. Kemp et al.

    Repetitive proteins and genes of malaria

    Annu. Rev. Microbiol.

    (1987)
  • B. Wahlin et al.

    Human antibodies to a Mr 155 000 Plasmodium falciparum antigen efficiently inhibit merozoite invasion

  • A. Saul et al.

    Invasion of erythrocytes in vitro by Plasmodium falciparum can be inhibited by monoclonal antibody directed against an S antigen

    Parasite Immunol.

    (1985)
  • H.S. Banyal et al.

    Isolation and characterization of parasite-inhibitory Plasmodium falciparum monoclonal antibodies

    Am. J. Trop. Med. Hyg.

    (1985)
  • Cited by (37)

    • Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate

      2011, Vaccine
      Citation Excerpt :

      Originally described under various names, including Pf140 [21], p113 [22], p126 [23], or SERP [24], serine repeat antigen 5 (SERA5) was first identified as an abundant, exported, soluble late-trophozoite and schizont stage protein of P. falciparum that accumulates in the parasitophorous vacuole, is released in soluble form at schizont rupture, and could induce antibodies that either protected against blood stage infection in vivo [21] or inhibited parasite growth in vitro [22]. Cloning of the first SERA gene revealed the presence of an extraordinarily serine rich amino terminal domain, on which the protein was renamed [25–27]. The primary sequence exhibits a secretory signal sequence with no membrane anchor domain, consistent with the highly soluble nature of the protein.

    • Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth

      2002, Journal of Biological Chemistry
      Citation Excerpt :

      Transcriptional profile among the SERA multigene family measured by RT-PCR with limited PCR cycles (Fig. 2), the Northern blot analysis (Fig. 3), and the real time quantitative PCR (Fig. 4) consistently showed that the abundance of SERA5 RNA was always higher than those of other SERA genes and was in 3–5-fold excess of MSP-1 RNA. This observation is in good accord with the previous report that SERA5 cDNA copies were abundant, since 0.5–1.5% of clones are SERA cDNAs in the cDNA library constructed from poly(A) RNA of erythrocytic stage P. falciparum parasites (38). Almost all of the SERA multigene family genes examined here were most actively transcribed in trophozoite and schizont stages (Fig. 5).

    View all citing articles on Scopus

    Present address: Department of Biology, Faculty of Science, Osaka University, Toyonaka, Osaka 560, Japan.

    View full text